Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Minimum inhibitory concentration (MIC) of antibiotics against cutaneous bacterial pathogens

From: Antibacterial effect of Ishige okamurae extract against cutaneous bacterial pathogens and its synergistic antibacterial effect against Pseudomonas aeruginosa

Strains MIC (μg/mL)
Amikacin Ceftazidime Ciprofloxacin Meropenem
Staphylococcus aureus KCTC 1927 1 2 0.5 1
Staphylococcus epidermidis ACTC 14990 1 4 4 1
Propionibacterium acnes KCTC 3314 4 0.5 4 4
Pseudomonas aeruginosa KCTC1637 1 8 8 16
P. aeruginosa isolate 366 2 4 4 8
P. aeruginosa isolate 4068 1 16 16 16
P. aeruginosa isolate 4135 1 8 16 8
P. aeruginosa isolate 4561 2 16 16 16
MIC breakpointa 4–8 1–4 2–8 8
  1. aEUCAST European committee on antimicrobial susceptibility testing